Yujiro Naito
-
- Immune Cell Function and Interaction 4
- Immunotherapy and Immune Responses 4
-
- Cancer Immunotherapy and Biomarkers 6
- Lung Cancer Research Studies 5
- CAR-T cell therapy research 4
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 3
-
- Neuroendocrine Tumor Research Advances 3
- Co-authors
- Shohei KoyamaAtsushi KumanogohAusten RiggsMingrui ZhuEsra A. AkbayKwok‐Kin WongYvonne Y. LiMin Wu
- Cited by
- ImmunologyOncologyGenetics
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Cancer Research (1 paper)Scientific Reports (3 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Yujiro Naito
27 papers receiving 380 citations
Peers
Comparison fields: 5 of 66
- Immunology 138
- Oncology 177
- Genetics 27
- Biotechnology 22
- Pulmonary and Respiratory Medicine 73
Countries citing papers authored by Yujiro Naito
This map shows the geographic impact of Yujiro Naito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujiro Naito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujiro Naito more than expected).
Fields of papers citing papers by Yujiro Naito
This network shows the impact of papers produced by Yujiro Naito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujiro Naito. The network helps show where Yujiro Naito may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yujiro Naito, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 4 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 2 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 9 | |
| 14 | 2021 | 56 | |
| 15 | 2021 | 11 | |
| 16 | 2021 | 9 | |
| 17 | 2019 | 19 | |
| 18 | 2019 | 108 | |
| 19 | 2017 | 3 | |
| 20 | 2017 | 19 |
About Yujiro Naito
Yujiro Naito is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 386 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), CAR-T cell therapy research (4 papers), Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Immunology (138 citations), Oncology (177 citations) and Genetics (27 citations). Yujiro Naito has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Shohei Koyama, Atsushi Kumanogoh, Austen Riggs, Mingrui Zhu, Esra A. Akbay, Kwok‐Kin Wong, Yvonne Y. Li, Min Wu, Wei Huang and Peter S. Hammerman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.